Wealth Enhancement Advisory Services, LLC Ironwood Pharmaceuticals Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 154,388 shares of IRWD stock, worth $296,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,388
Previous 125,460
23.06%
Holding current value
$296,424
Previous $90,000
124.44%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IRWD
# of Institutions
181Shares Held
159MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$43.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$31.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$31 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$30.6 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$16.1 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $294M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...